Irinotecan and Bevacizumab for Recurrent Ovarian Cancer - Wikidata - awgldk - TriplyDB

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

http://www.wikidata.org/entity/Q61937103

about

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

http://www.wikidata.org/entity/Q61937103

description

clinical trial

@en

klinisch onderzoek

@nl

name

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

@en

type

label

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

@en

prefLabel

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

@en

P1132

Q61937103-5B65AD4C-CBA0-43C1-8F7A-768EE8D2B0D4

P1476

Q61937103-3011A88D-9EC4-40E6-BC51-EE4460D08C9E

P17

Q61937103-BDD77067-7985-4975-A4C3-F48C53A570F7

P2899

Q61937103-85FEB370-7913-421A-BE24-23E7CA67B4CD

P3098

Q61937103-363DC9D2-EB52-4248-8288-AEB5CF1F8A53

P31

Q61937103-C398124E-D7E2-4A16-9376-3FF5E80F48C8

P4844

Q61937103-7F831A7D-7EB1-4BE9-8F7E-16E3F19511F6

Q61937103-9678F6AC-0193-4A43-A8CC-8CCB57490847

Q61937103-CE15A9E2-8E53-41BB-93AD-39F6494054A4

P580

Q61937103-CB7102FA-1D12-42B9-AAB1-FC3EA58DA19D

P582

Q61937103-3F0B81A9-475D-4013-916F-ACBA93B924F3

P6099

Q61937103-10E79D56-F7B4-4D0A-B462-C60F69D54A76

P6153

Q61937103-578A4329-EE31-4383-A12D-C36B2F8C38EB

P8005

Q61937103-F4464D8B-9690-40A7-BD0C-7FD268F98E42

P859

Q61937103-254CC4CF-C321-42A2-9870-8E6E57069892

P1132

29

http://www.w3.org/2001/XMLSchema#decimal

P1476

Phase II Study of Irinotecan i ...... t of Recurrent Ovarian Cancer.

@en

P17

Ameeriga Ütisriigiq

P2899

18

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT01091259

http://www.w3.org/2001/XMLSchema#string

P31

P4844

P580

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P6153

New York University

P8005

P859

New York University School of Medicine